Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells
Cancer is a leading cause of death among the various diseases encountered in humans. Cancer is not a single entity and consists of numerous different types and subtypes that require various treatment regimens. In the last decade, several milestones in cancer treatments were accomplished, such as spe...
Main Authors: | Megan Jung, Indy Bui, Benjamin Bonavida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/17/4267 |
Similar Items
-
Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer
by: Yumin Wei, et al.
Published: (2023-06-01) -
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer
by: Natalie Yan Li Ngoi, et al.
Published: (2020-03-01) -
Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases
by: Emma C. Josefsson, et al.
Published: (2020-10-01) -
EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax
by: Katie Fooks, et al.
Published: (2022-12-01) -
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
by: Ana Dillen, et al.
Published: (2024-03-01)